Head to Head Analysis Sunshine Biopharma (NASDAQSBFM) & U.S. Stem Cell (OTCMKTSUSRM)

MONTRÉAL, Dec. 12, 2022 (GLOBE NEWSWIRE) — ExCellThera Inc. (ExCellThera), a world leader in blood stem cell expansion and rejuvenation, announced today findings from a safety and efficacy retrospective analysis comparing outcomes of patients treated with ECT-001 (UM171-expanded) Cell Therapy in a Phase 1/2 trial to those treated with cord blood and matched unrelated donor […]

Scientists designed a mathematical model to replicate how specialized viruses called bacteriophages can treat mice with pneumonia. This model could help researchers develop new treatments for similar bacterial infections.

Researchers find that childhood neglect and abuse can accelerate aging, leaving those affected vulnerable to age-related diseases like dementia.

The event is expected to focus on ways to give women equal access to STEM (Science, Technology, Engineering, and Mathematics) education, research opportunities, and economic participation.

(marketscreener.com) BioLineRx Reports Second Quarter 2022 Financial Results and Provides Corporate Update - Submission of New Drug Application to FDA for Motixafortide in stem cell mobilization for autologous stem cell transplantation expected within next 4-6...https//www.marketscreener.com/quote/stock/BIOLINERX-LTD-120962327/news/BioLineRx-Reports-Second-Quarter-2022-Financial-Results-and-Provides-Corporate-Update-Form-6-K-41329729/?utm_medium=RSS&utm_content=20220816

On January 15th, 2022, the underwater volcano Hunga Tonga-Hunga Ha’apai violently erupted, spewing an immense plume of ash and gas into the air. The explosion occurred in the midst of the Pacific Ocean near the island chain of Tonga, and caused a tsunami that swept the ocean and pressure waves that circled the Earth for days. Explosive volcanic eruptions like Hunga Tonga pose an immediate threat to nearby communities and disrupt local air travel. They also release gasses like sulfur dioxide that can have long-term effects on the climate. When enough sulfur dioxide is released from a volcano...

There is a stem cell revolution on the way, but it isn't the regenerative medicine some people are pushing, say John E. J. Rasko and Carl Power

Research reveals a promising stem cell approach to correct photoreceptor cell degeneration, which underlies several forms of visual decline and blindness.

Bank of America initiated coverage on shares of Stem (NYSESTEM – Get Rating) in a research note published on Friday morning, The Fly reports. The firm issued a neutral rating and a $11.00 target price on the stock. Several other equities analysts have also recently commented on STEM. Morgan Stanley upgraded shares of Stem from […]

Cells in the blood such as immune cells, red blood cells and other vital cell types are constantly renewed from stem cells, the so-called hematopoietic stem and progenitor cells (HSPCs). Certain diseases of the blood system, such as genetic diseases or leukemias, can be effectively treated by stem cell transplants, but suitable, genetically matched donors are not always available.

Stem (NYSESTEM – Get Rating) had its target price decreased by UBS Group from $19.00 to $18.00 in a report issued on Sunday morning, The Fly reports. Several other equities research analysts have also issued reports on the company. Guggenheim set a $17.00 price objective on Stem in a research note on Thursday, September 29th. […]

Bank of America initiated coverage on shares of Stem (NYSESTEM – Get Rating) in a research note published on Friday morning, The Fly reports. The firm issued a neutral rating and a $11.00 target price on the stock. Several other equities analysts have also recently commented on STEM. Morgan Stanley upgraded shares of Stem from […]

On January 15th, 2022, the underwater volcano Hunga Tonga-Hunga Ha’apai violently erupted, spewing an immense plume of ash and gas into the air. The explosion occurred in the midst of the Pacific Ocean near the island chain of Tonga, and caused a tsunami that swept the ocean and pressure waves that circled the Earth for days. Explosive volcanic eruptions like Hunga Tonga pose an immediate threat to nearby communities and disrupt local air travel. They also release gasses like sulfur dioxide that can have long-term effects on the climate. When enough sulfur dioxide is released from a volcano...

A newly elected Missouri state representative and assistant physician faces charges for allegedly running a fraud scheme in her three clinics and providing prescription drugs illegally, according to federal prosecutors.

The body is constantly replenishing the blood with new red and white blood cells thanks to a small but important group of cells called hematopoietic stem cells (HSCs). Now, researchers at the Broad Institute of MIT Harvard, Boston Children's Hospital, and Dana-Farber Cancer Institute have found that these cells are particularly vulnerable to ferroptosis, a kind of cell death triggered by iron.

Direct protein crystallization is a key component of the novel cell-free protein crystallization (CFPC) technology developed by Tokyo Tech, which represents a significant advancement in structural biology. This method will make it possible to study unstable proteins that could not be examined in the past. Studying these in-depth will help us learn more about how […]The post Structural Biology Hits A Breakthrough Finds New Cell-free Protein Crystallization Method appeared first on Revyuh.

(marketscreener.com) Based at EastSide Charter School, the Chemours STEM Hub will support improved access to STEM education in the Wilmington, Del. communityhttps//www.marketscreener.com/quote/stock/THE-CHEMOURS-COMPANY-22795876/news/Chemours-and-EastSide-Charter-School-Break-Ground-on-the-New-Chemours-STEM-Hub-42871207/?utm_medium=RSS&utm_content=20230201

(marketscreener.com) Meeting expected to occur within 30 days of the FDA's receipt of the meeting requestNEW YORK, Dec. 12, 2022 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced that the company has submitted a Type A Meeting Request to the U.S. Food and...https//www.marketscreener.com/quote/stock/BRAINSTORM-CELL-THERAPEUT-18118014/news/BrainStorm-Cell-Therapeutics-Submits-Type-A-Meeting-Request-to-U-S-Food-and-Drug-Administration-42526499/?utm_medium=RSS&utm_content=20221212

Scientists show changing the types of artificial lights used in tourist caves can help prevent growth of algae that damage stalactites and other cave features.

Stem (NYSESTEM) Stock Price Up 4.6%

Scientists have shown that urban bird, mammal and reptile microbiomes are similar to those of humans. This is one example of how urbanization is impacting ecosystems worldwide.

MONTREAL, Nov. 08, 2022 (GLOBE NEWSWIRE) — ExCellThera Inc. (ExCellThera), a world leader in blood stem cell expansion and rejuvenation, announced today that its proprietary ECT-001 Cell Therapy has been administered to 100 patients. ECT-001 Cell Therapy is an investigational UM171-expanded cord blood cell therapy being evaluated in trials across multiple adult and pediatric hematological […]

(marketscreener.com) In recent years, the significant potential of regenerative medicine and cell therapy have been established in particular in areas that have traditionally been difficult to address with conventional chemically synthesized low molecular weight drugs1 or biopharmaceuticals,2 such as the restoration of tissues and functions lost as a...https//www.marketscreener.com/quote/stock/SYSMEX-CORPORATION-6492200/news/Sysmex-and-JCR-Pharmaceuticals-Establish-a-Joint-Venture-in-the-Field-of-Regenerative-Medicine-and-41911205/?utm_medium=RSS&utm_content=20221003

(marketscreener.com) - PDUFA target action date set for September 9, 2023- NDA submission based on GENESIS Phase 3 trial data that met all primary and secondary endpoints with a high level of statistical significance- Company advancing preparations for robust commercial launchTEL AVIV, Israel, Nov. 10, 2022 /PRNewswire/ -- BioLineRx Ltd. , a pre-commercial-stage...https//www.marketscreener.com/quote/stock/BIOLINERX-LTD-61956566/news/BioLineRx-Announces-U-S-FDA-Acceptance-of-New-Drug-Application-for-APHEXDA-motixafortide-in-Stem-42269162/?utm_medium=RSS&utm_content=20221110

(marketscreener.com) PHILADELPHIA, Nov. 02, 2022 -- Century Therapeutics , an innovative biotechnology company developing induced pluripotent stem cell -derived cell therapies in immuno-oncology, today announced that it will host a virtual Research and Development Day on Friday, November 11, 2022, from 800 AM to 930 AM ET. The R&D Day will feature...https//www.marketscreener.com/quote/stock/CENTURY-THERAPEUTICS-INC-123820661/news/Century-Therapeutics-to-Host-Virtual-Research-and-Development-Day-on-November-11-2022-42176488/?utm_medium=RSS&utm_content=20221102

A new research paper was published on the cover of Aging entitled "Single-cell transcriptomics of peripheral blood in the aging mouse."

(marketscreener.com) PHILADELPHIA, Oct. 03, 2022 -- Century Therapeutics , an innovative biotechnology company developing induced pluripotent stem cell -derived cell therapies in immuno-oncology, today announced the appointment of Daphne Quimi and Timothy Walbert to the Company’s Board of Directors. Ms. Quimi is currently Chief Financial Officer of Amicus...https//www.marketscreener.com/quote/stock/CENTURY-THERAPEUTICS-INC-123820661/news/Century-Therapeutics-Announces-Appointment-of-Daphne-Quimi-and-Timothy-Walbert-to-its-Board-of-Direc-41913578/?utm_medium=RSS&utm_content=20221003

Robert W. Baird started coverage on shares of Lineage Cell Therapeutics (NYSEAMERICANLCTX – Get Rating) in a research report released on Tuesday, The Fly reports. The firm issued an outperform rating and a $5.00 price objective on the stock. Lineage Cell Therapeutics Stock Down 0.7 % Lineage Cell Therapeutics stock opened at $1.37 on Tuesday. […]

Here are the toymakers and brands who are lending a helping hand to science, technology, engineering and math (STEM) education.

Two people with beta thalassaemia and one with sickle cell disease no longer need blood transfusions after their blood stem cells were gene edited and put back in their bodies

Breakthrough solution aims to solve cell transplant rejection issues, paving the way for progress in cellular transplantation and immunotherapy. Researchers at UCSF have come up with a new method that could save lives by stopping antibodies from making the immune system reject engineered therapeutic and transplant cells. Rejection caused by antibodies, as opposed to the […]The post Revolutionary New Method Offers Hope For Successful Cell Transplants appeared first on Revyuh.

Scientists designed a mathematical model to replicate how specialized viruses called bacteriophages can treat mice with pneumonia. This model could help researchers develop new treatments for similar bacterial infections.

Head to Head Analysis Sunshine Biopharma (NASDAQSBFM) & U.S. Stem Cell (OTCMKTSUSRM)

(marketscreener.com) PHILADELPHIA, Oct. 03, 2022 -- Century Therapeutics , an innovative biotechnology company developing induced pluripotent stem cell -derived cell therapies in immuno-oncology, today announced the appointment of Daphne Quimi and Timothy Walbert to the Company’s Board of Directors. Ms. Quimi is currently Chief Financial Officer of...https//www.marketscreener.com/quote/stock/CENTURY-THERAPEUTICS-INC-123820661/news/Century-Therapeutics-Announces-Appointment-of-Daphne-Quimi-and-Timothy-Walbert-to-its-Board-of-Direc-41913579/?utm_medium=RSS&utm_content=20221003

The body is constantly replenishing the blood with new red and white blood cells thanks to a small but important group of cells called hematopoietic stem cells (HSCs). Now, researchers at the Broad Institute of MIT Harvard, Boston Children's Hospital, and Dana-Farber Cancer Institute have found that these cells are particularly vulnerable to ferroptosis, a kind of cell death triggered by iron.

Stem (NYSESTEM) Sees Unusually-High Trading Volume

(marketscreener.com) Cultural icon Serena Williams keynotes MetLife’s 4th annual Triangle Tech X Conference focused on new findings and “Inspiring the Next Innovation Wave”https//www.marketscreener.com/quote/stock/METLIFE-INC-13496/news/MetLife-Research-Shows-Urgent-Need-for-More-Women-in-STEM-to-Solve-Global-Challenges-42344281/?utm_medium=RSS&utm_content=20221117

Betty Vandenbosch is the Chief Content Officer at Coursera, and has been in STEM for more than 40 years. Her extensive experience in the education fields highlights her passion for enriching the lives of young people through advancing their learning at all levels.

MONTREAL, Nov. 08, 2022 (GLOBE NEWSWIRE) — ExCellThera Inc. (ExCellThera), a world leader in blood stem cell expansion and rejuvenation, announced today that its proprietary ECT-001 Cell Therapy has been administered to 100 patients. ECT-001 Cell Therapy is an investigational UM171-expanded cord blood cell therapy being evaluated in trials across multiple adult and pediatric hematological […]

????????????????????,???????????,??????????????Archon Wellness???????????,??????????????

Stem (NYSESTEM – Get Rating) received a $17.00 price target from Guggenheim in a research note issued on Thursday, The Fly reports. Guggenheim’s target price points to a potential upside of 27.44% from the company’s current price. Several other brokerages also recently weighed in on STEM. Cowen initiated coverage on Stem in a research report […]

Stem (NYSESTEM – Get Rating) received a $17.00 price target from Guggenheim in a research note issued on Thursday, The Fly reports. Guggenheim’s target price points to a potential upside of 27.44% from the company’s current price. Several other brokerages also recently weighed in on STEM. Cowen initiated coverage on Stem in a research report […]

Clinics, including some in the US, offer stem cells, false hopes, and risks.

(marketscreener.com) ROCKVILLE, Md., Nov. 02, 2022 -- MaxCyte, Inc., , a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research, today announced Company management will participate in the...https//www.marketscreener.com/quote/stock/MAXCYTE-INC-26786499/news/MaxCyte-to-Participate-in-Upcoming-Investor-Conferences-42177372/?utm_medium=RSS&utm_content=20221102

Research reveals a promising stem cell approach to correct photoreceptor cell degeneration, which underlies several forms of visual decline and blindness.

Researchers find that childhood neglect and abuse can accelerate aging, leaving those affected vulnerable to age-related diseases like dementia.

(marketscreener.com) NEW YORK, Jan. 5, 2023 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced that Chaim Lebovits, President and CEO, and Stacy Lindborg, Co-CEO, will jointly present a corporate and clinical overview at 1030 a.m. PT on Monday, Jan. 9 at...https//www.marketscreener.com/quote/stock/BRAINSTORM-CELL-THERAPEUT-18118014/news/BrainStorm-Cell-Therapeutics-to-Present-at-Biotech-Showcase-trade-2023-42665197/?utm_medium=RSS&utm_content=20230105

San Jose, California–(Newsfile Corp. – December 14, 2022) – Wearing custom cleats designed by Sickle Cell 101, scoring a game-changing touchdown, and winning the AFC Special Teams Player Of The Week, all while advocating for sickle cell—that’s Cleveland Browns’ wide receiver Donovan Peoples-Jones courageously supporting sickle cell for the third year in a row through […]

Hemogenyx to get Chinese patent for use of antibody in stem cell transplant